Cargando…
Clinical Candidates Targeting the ATR–CHK1–WEE1 Axis in Cancer
SIMPLE SUMMARY: Selective killing of cancer cells is privileged mainstream in cancer treatment and targeted therapy represents the new tool with a potential to pursue this aim. It can also aid to overcome resistance of conventional chemo- or radio-therapy. Common mutations of cancer cells (defective...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918546/ https://www.ncbi.nlm.nih.gov/pubmed/33672884 http://dx.doi.org/10.3390/cancers13040795 |